Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.

Abolmaali, Meysam; Rezania, Fatemeh; Behnagh, Arman Karimi; Hamidabad, Negin Mahmoudi; Gorji, Ali; Mirzaasgari, Zahra

Abolmaali, Meysam; Rezania, Fatemeh; Behnagh, Arman Karimi; Hamidabad, Negin Mahmoudi; Gorji, Ali; Mirzaasgari, Zahra.

Afiliação

Abolmaali M; Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
Rezania F; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Behnagh AK; Clinical Neurosciences, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
Hamidabad NM; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Gorji A; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mirzaasgari Z; Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.

Immunol Res ; 70(6): 752-764, 2022 12.

Article em En | MEDLINE | ID: mdl-36098903

Assuntos

Vacinas contra COVID-19; COVID-19; Síndrome de Guillain-Barré; Vacinas; Adulto; Idoso; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; COVID-19/prevenção & controle; Vacinas contra COVID-19/efeitos adversos; Síndrome de Guillain-Barré/epidemiologia; Síndrome de Guillain-Barré/etiologia; Vacinação/efeitos adversos; Vacinas/efeitos adversos

Palavras-chave

COVID-19; Guillain-Barré syndrome; SARS-COV-2; Vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Síndrome de Guillain-Barré / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google